Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.
A pioneering clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson\u2019s has recruited its first UK participant from the Discovery Cohort study at the Oxford Parkinson\u2019s Disease Centre (OPDC)
Professor Sir Aziz Sheikh OBE gave his inaugural lecture at the University of Oxford, sharing his vision for transforming global health care through data, innovation and equity.
Scientists from the Ineos Oxford Institute for antimicrobial research (IOI) have developed a new screening method to tackle bacterial resistance to the tetracycline class of antibiotics. The results from this method provide the starting point to develop new drugs to treat drug-resistant infections. The findings have been published in Chemical Science.
Last week, the National Academy of Sciences in the US announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues\u2014addressing a major challenge in current immunotherapy.
Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).
Researchers at Oxford Population Health studying genetic variants that control levels of Lipoprotein(a), or Lp(a) discovered that lowering Lp(a) could reduce the risk of heart attack and large artery stroke in both East Asians and Europeans. The study is published in Circulation.
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Professor Ole Jensen is part of a global consortium that embraced a novel collaborative approach to investigating one of the brain\u2019s greatest mysteries
A collaborative study between the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division at the University of Oxford has been awarded the 2024 PNAS Cozzarelli Prize in Biomedical Science.
A major study in The Lancet Infectious Diseases confirms that single low-dose primaquine is safe and effective in reducing malaria transmission in young children. Analysing data from over 6,000 patients, researchers found it effective even in young children and areas with high malaria burden.
Research published in the journal Human Reproduction reveals that women with endometriosis are at a significantly higher risk for developing a range of autoimmune, autoinflammatory, and mixed-pattern diseases.
On the 25 and 26 April the MSc in International Health and Tropical Medicine, IHTM, celebrated its tenth anniversary as an internationally renowned programme for future global health leaders, with over 100 alumni travelling from around the world to join colleagues, current students and guests in Oxford.
Results of two parallel studies show that one in four African children hospitalised with malaria and coma have an additional infection, and that giving antibiotics with antimalarials could help reduce death rates of comatose children.
A new study, co-lead by Dr Felipe Galvez-Cancino from the Centre for Immuno-Oncology, has shown that Treg cell depletion can suppress tumour growth in one of the deadliest types of cancer.
Academic Clinical Lecturer Mr Keaton Jones has been awarded a grant from Pancreatic Cancer UK to carry out pioneering pancreatic cancer research within the Nuffield Department of Surgical Sciences.
The climate crisis is a health emergency which is threatening the lives and wellbeing of communities around the world in many ways \u2013 including through air pollution, rising temperatures, the spread of infectious diseases and antimicrobial resistance.
![\"A](\"https://www.medsci.ox.ac.uk/news/study-identifies-key-immune-structures-in-the-gut-that-may-drive-coeliac-disease/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n